Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05068284
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 176
Large-scale testing (Phase 3)Study completedNCT00946946
What this trial is testing

Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine

Who this might be right for
Crohn's Disease
Dr. Falk Pharma GmbH 78
Post-approval studies (Phase 4)Looking for participantsNCT07564505
What this trial is testing

A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease

Who this might be right for
Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Early research (Phase 1)Study completedNCT02968108
What this trial is testing

A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 45
Testing effectiveness (Phase 2)Ended earlyNCT00584740
What this trial is testing

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT01155362
What this trial is testing

PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Celularity Incorporated 50
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Large-scale testing (Phase 3)Study completedNCT00207662
What this trial is testing

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 580
Large-scale testing (Phase 3)Ended earlyNCT03566823
What this trial is testing

Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)

Who this might be right for
Crohn's Disease
Shire 34
Large-scale testing (Phase 3)Looking for participantsNCT06059989
What this trial is testing

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Who this might be right for
Inflammatory DiseaseDisease CrohnBowel Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 158
Early research (Phase 1)Looking for participantsNCT07758101
What this trial is testing

Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease

Who this might be right for
Moderate-to-severe Inflammatory Bowel Disease
Guangdong Hengrui Pharmaceutical Co., Ltd 88
Large-scale testing (Phase 3)Study completedNCT03234907
What this trial is testing

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Who this might be right for
Crohn's Disease
Takeda 215
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677514
What this trial is testing

A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd. 156
Large-scale testing (Phase 3)Looking for participantsNCT06332534
What this trial is testing

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Not applicableLooking for participantsNCT07123207
What this trial is testing

Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Disease

Who this might be right for
Mild to Severe Crohns Disease
The Third Xiangya Hospital of Central South University 24
Large-scale testing (Phase 3)Study completedNCT02499783
What this trial is testing

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 205
Not applicableNo Longer AvailableNCT03362736
What this trial is testing

An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT02877134
What this trial is testing

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 388
Large-scale testing (Phase 3)Study completedNCT01369342
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Who this might be right for
Crohn's DiseaseInflammatory Bowel DiseaseIBD+1 more
Janssen Research & Development, LLC 640
Testing effectiveness (Phase 2)Study completedNCT02378688
What this trial is testing

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 78
Next Page